Epidermal barrier formation and recovery in skin disorders

Journal of Clinical Investigation

Volumn 116, Issue 5, 2006, Pages 1150-1158

  Segre, Julia A ^a,b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b MSC 4442 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOPIC DERMATITIS; CONGENITAL SKIN DISEASE; EPIDERMIS; GENE MUTATION; GENETIC LINKAGE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN CELL; SKIN DISEASE; SKIN INFLAMMATION; SKIN STRUCTURE;

ANIMALS; CELL DIFFERENTIATION; EPIDERMIS; HUMANS; MODELS, ANATOMIC; MODELS, BIOLOGICAL; SKIN DISEASES;

EID: 33646429507     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28521     Document Type: Review

References (90)

1. Ito, M., et al. 2005. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat. Med. 11:1351-1354.
2. Fuchs, E., and Raghavan, S. 2002. Getting under the skin of epidermal morphogenesis. Nat. Rev. Genet. 3:199-209.
3. Niemann, C., and Watt, F.M. 2002. Designer skin: lineage commitment in postnatal epidermis. Trends Cell Biol. 12:185-192.
4. Elias, P.M. 1983. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80:44s-49s.
5. Kalinin, A.E., Kajava, A.V., and Steinert, P.M. 2002. Epithelial barrier function: assembly and structural features of the cornified cell envelope. Bioessays. 24:789-800.
6. Nemes, Z., and Steinert, P.M. 1999. Bricks and mortar of the epidermal barrier. Exp. Mol. Med. 31:5-19.
7. Furuse, M., et al. 2002. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J. Cell Biol. 156:1099-1111.
8. Steinert, P.M. 2000. The complexity and redundancy of epithelial barrier function. J. Cell Biol. 151:F5-F8.
9. Segre, J. 2003. Complex redundancy to build a simple epidermal permeability barrier. Curr. Opin. Cell Biol. 15:776-782.
10. Morita, K., et al. 2002. Molecular architecture of tight junctions of periderm differs from that of the maculae occludentes of epidermis. J. Invest. Dermatol. 118:1073-1079.
11. Kalia, Y.N., Nonato, L.B., Lund, C.H., and Guy, R.H. 1998. Development of skin barrier function in premature infants. J. Invest. Dermatol. 111:320-326.
12. Aszterbaum, M., Feingold, K.R., Menon, G.K., and Williams, M.L. 1993. Glucocorticoids accelerate fetal maturation of the epidermal permeability barrier in the rat. J. Clin. Invest. 91:2703-2708.
13. Hardman, M.J., Sisi, P., Banbury, D.N., and Byrne, C. 1998. Patterned acquisition of skin barrier function during development. Development. 125:1541-1552.
14. Hanley, K., et al. 1998. Glucocorticoid deficiency delays stratum corneum maturation in the fetal mouse. J. Invest. Dermatol. 111:440-444.
15. Segre, J.A., Bauer, C., and Fuchs, E. 1999. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22:356-360.
16. Jaubert, J., Cheng, J., and Segre, J.A. 2003. Ectopic expression of kruppel like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier. Development. 130:2767-2777.
17. Marshall, D., Hardman, M.J., Nield, K.M., and Byrne, C. 2001. Differentially expressed late constituents of the epidermal cornified envelope. Proc. Natl. Acad. Sci. U. S. A. 98:13031-13036.
18. Richard, G. 2004. Molecular genetics of the ichthyoses. Am. J. Med. Genet. C Semin. Med. Genet. 131C:32-44.
19. Huber, M., et al. 1995. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science. 267:525-528.
20. Russell, L.J., et al. 1995. Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nat. Genet. 9:279-283.
21. Lefevre, C., et al. 2003. Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2. Hum. Mol. Genet. 12:2369-2378.
22. Lefevre, C., et al. 2006. Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum. Mol. Genet. 15:767-776.
23. Jobard, F., et al. 2002. Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1. Hum. Mol. Genet. 11:107-113.
24. Lefevre, C., et al. 2004. Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis. Hum. Mol. Genet. 13:2473-2482.
25. Williams, M.L., and Elias, P.M. 1985. Heterogeneity in autosomal recessive ichthyosis. Clinical and biochemical differentiation of lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch. Dermatol. 121:477-488.
26. Kelsell, D.P., et al. 2005. Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am. J. Hum. Genet. 76:794-803.
27. Akiyama, M., et al. 2005. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J. Clin. Invest. 115:1777-1784. doi:10.1172/JCI24834.
28. Chavanas, S., et al. 2000. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat. Genet. 25:141-142.
29. Raghunath, M., et al. 2003. Self-healing collodion baby: a dynamic phenotype explained by a particular transglutaminase-1 mutation. J. Invest. Dermatol. 120:224-228.
30. Smith, F.J., et al. 2006. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat. Genet. 38:337-342.
31. Matsuki, M., et al. 1998. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc. Natl. Acad. Sci. U. S. A. 95:1044-1049.
32. Kuramoto, N., et al. 2002. Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1. J. Clin. Invest. 109:243-250. doi:10.1172/JCI200213563.
33. Koch, P.J., et al. 2000. Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J. Cell Biol. 151:389-400.
34. Presland, R.B., et al. 2000. Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J. Invest. Dermatol. 115:1072-1081.
35. Wakabayashi, N., et al. 2003. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35:238-245.
36. Takagi, S., et al. 2003. Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function. J. Clin. Invest. 112:1372-1382. doi:10.1172/JCI200318513.
37. Ting, S.B., et al. 2005. A homolog of Drosophila grainy head is essential for epidermal integrity in mice. Science. 308:411-413.
38. Indra, A.K., et al. 2005. TAF10 is required for the establishment of skin barrier function in foetal, but not in adult mouse epidermis. Dev. Biol. 285:28-37.
39. Leyvraz, C., et al. 2005. The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J. Cell Biol. 170:487-496.
40. List, K., et al. 2002. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene. 21:3765-3779.
41. Tunggal, J.A., et al. 2005. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J. 24:1146-1156.
42. Moskowitz, D.G., et al. 2004. Pathophysiologic basis for growth failure in children with ichthyosis: an evaluation of cutaneous ultrastructure, epidermal permeability barrier function, and energy expenditure. J. Pediatr. 145:82-92.
43. Esche, C., de Benedetto, A., and Beck, L.A. 2004. Keratinocytes in atopic dermatitis: inflammatory signals. Curr. Allergy Asthma Rep. 4:276-284.
44. Ghadially, R., Reed, J.T., and Elias, P.M. 1996. Stratum corneum structure and function correlates with phenotype in psoriasis. J. Invest. Dermatol. 107:558-564.
45. Leung, D.Y., Boguniewicz, M., Howell, M.D., Nomura, I., and Hamid, Q.A. 2004. New insights into atopic dermatitis. J. Clin. Invest. 113:651-657. doi:10.1172/JCI200421060.
46. Nickoloff, B.J., and Nestle, F.O. 2004. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J. Clin. Invest. 113:1664-1675. doi:10.1172/JCI200422147.
47. Johansson, S.G., et al. 2001. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 56:813-824.
48. Sator, P.G., Schmidt, J.B., and Honigsmann, H. 2003. Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J. Am. Acad. Dermatol. 48:352-358.
49. Capon, F., et al. 2001. Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J. Invest. Dermatol. 116:728-730.
50. Cookson, W.O., et al. 2001. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat. Genet. 27:372-373.
51. Palmer, C.N.A., et al. 2006. Common loss-of-funtion variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. doi:10.1038/ng1767.
52. Spergel, J.M., and Paller, A.S. 2003. Atopic dermatitis and the atopic march. J. Allergy Clin. Immunol. 112:S118-S127.
53. Spergel, J.M., et al. 1998. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101:1614-1622.
54. Walley, A.J., et al. 2001. Gene polymorphism in Netherton and common atopic disease. Nat. Genet. 29:175-178.
55. Descargues, P., et al. 2005. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat. Genet. 37:56-65.
56. Cookson, W. 2004. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat. Rev. Immunol. 4:978-988.
57. Zenz, R., et al. 2005. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature. 437:369-375.
58. Broome, A.M., Ryan, D., and Eckert, R.L. 2003. S100 protein subcellular localization during epidermal differentiation and psoriasis. J. Histochem. Cytochem. 51:675-685.
59. Sun, C., et al. 2006. Peptidoglycan recognition proteins Pglyrp3 and Pglyrp4 are encoded from the epidermal differentiation complex and are candidate genes for the Psors4 locus on chromosome 1q21. Hum. Genet. 119:113-125.
60. Patel, S., Kartasova, T., and Segre, J.A. 2003. Mouse Sprr locus: a tandem array of coordinately regulated genes. Mamm. Genome. 14:140-148.
61. Zhou, X., et al. 2003. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol. Genomics. 13:69-78.
62. Zimmermann, N., et al. 2005. Expression and regulation of small proline-rich protein 2 in allergic inflammation. Am. J. Respir. Cell Mol. Biol. 32:428-435.
63. Hooper, L.V., et al. 2001. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 291:881-884.
64. Nozaki, I., et al. 2005. Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab. Invest. 85:109-123.
65. Pradervand, S., et al. 2004. Small proline-rich protein 1A is a gp130 pathway- and stress-inducible cardioprotective protein. EMBO J. 23:4517-4525.
66. Ghadially, R., Brown, B.E., Sequeira-Martin, S.M., Feingold, K.R., and Elias, P.M. 1995. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J. Clin. Invest. 95:2281-2290.
67. Nickoloff, B.J., and Naidu, Y. 1994. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J. Am. Acad. Dermatol. 30:535-546.
68. Proksch, E., Feingold, K.R., Man, M.Q., and Elias, P.M. 1991. Barrier function regulates epidermal DNA synthesis. J. Clin. Invest. 87:1668-1673.
69. Wood, L.C., Jackson, S.M., Elias, P.M., Grunfeld, C., and Feingold, K.R. 1992. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J. Clin. Invest. 90:482-487.
70. Wood, L.C., et al. 1996. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J. Invest. Dermatol. 106:397-403.
71. Li, A.G., Wang, D., Feng, X.H., and Wang, X.J. 2004. Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J. 23:1770-1781.
72. Sano, S., et al. 2005. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 11:43-49.
73. Labarthe, M.P., Bosco, D., Saurat, J.H., Meda, P., and Salomon, D. 1998. Upregulation of connexin 26 between keratinocytes of psoriatic lesions. J. Invest. Dermatol. 111:72-76.
74. Lucke, T., et al. 1999. Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. J. Invest. Dermatol. 112:354-361.
75. Richard, G. 2005. Connexin disorders of the skin. Clin. Dermatol. 23:23-32.
76. Djalilian, A.R., et al. 2006. Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J. Clin. Invest. 116:1243-1253. doi:10.1172/JCI27186.
77. Suetake, T., Sasai, S., Zhen, Y.X., Ohi, T., and Tagami, H. 1996. Functional analyses of the stratum corneum in scars. Sequential studies after injury and comparison among keloids, hypertrophic scars, and atrophic scars. Arch. Dermatol. 132:1453-1458.
78. Ying, S., et al. 2005. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J. Immunol. 174:8183-8190.
79. Soumelis, V., et al. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol. 3:673-680.
80. Zhou, B., et al. 2005. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 6:1047-1053.
81. Yoo, J., et al. 2005. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 202:541-549.
82. Al-Shami, A., Spolski, R., Kelly, J., Keane-Myers, A., and Leonard, W.J. 2005. A role for TSLP in the development of inflammation in an asthma model. J. Exp. Med. 202:829-839.
83. Kao, J.S., et al. 2003. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J. Invest. Dermatol. 120:456-464.
84. Lee, T.I., et al. 2002. Transcriptional regulatory networks in Saccharomyces cerevisiae. Science. 298:799-804.
85. Huppi, K., Martin, S.E., and Caplen, N.J. 2005. Defining and assaying RNAi in mammalian cells. Mol. Cell. 17:1-10.
86. ENCODE Project consortium. 2004. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science. 306:636-640.
87. Lindblad-Toh, K., et al. 2005. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature. 438:803-819.
88. Helms, C., et al. 2003. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat. Genet. 35:349-356.
89. King, D.C., et al. 2005. Evaluation of regulatory potential and conservation scores for detecting cis-regulatory modules in aligned mammalian genome sequences. Genome Res. 15:1051-1060.
90. Martin, N., Patel, S., and Segre, J.A. 2004. Long-range comparison of human and mouse Sprr loci to identify conserved noncoding sequences involved in coordinate regulation. Genome Res. 14:2430-2438.